Clinical Trials in North Carolina

Showing 1541-1560 of 9,731 trials

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

NCT06652100

The purpose of this research is to collect blood and urine from adult patients admitted to an intensive care unit. This is to assess the performance of the ProNephro AKI (NGAL) assay (lab test) as an aid to identify patients at risk for acute kidney injury.

Acute Kidney Injury

BioPorto Diagnostics800 participantsStarted Oct 2024

Birmingham, Alabama, United States • Sacramento, California, United States • New Haven, Connecticut, United States +9 more locations

Active Not RecruitingPhase 341 miles

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

NCT05450692

This study will assess the efficacy and safety of the combination of ceralasertib and durvalumab versus standard of care docetaxel in patients with locally advanced and metastatic NSCLC after progression on prior anti-PD-(L)1 therapy and platinum-based chemotherapy.

Advanced or Metastatic Non-Small Cell Lung Cancer

AstraZeneca594 participantsStarted Sep 2022

Mobile, Alabama, United States • Chandler, Arizona, United States • Los Alamitos, California, United States +190 more locations

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Find Trials by Condition in North Carolina

Registry for Adults With Plasma Cell Disorders (PCD's)

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

The Synergy Disc To Anterior Cervical Discectomy and Fusion

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Allergic Disease Onset Prevention Study

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Study of AVZO-021 in Patients With Advanced Solid Tumors

Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

Pharmacogenomics for Better Treatment of Fungal Infections in Cancer